| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |